|
2016 |
Brain and White Matter Hyperintensity Volumes After 10 Years of Random Assignment to Lifestyle Intervention. |
Roberta Diaz Brinton, Ph.D |
|
2017 |
Bone morphogenetic protein-9 increases the functional expression of organic anion transporting polypeptide 1a4 at the blood-brain barrier via the activin receptor-like kinase-1 receptor. |
Thomas P Davis, PhD, Patrick T Ronaldson, PhD, FAAPS |
|
2022 |
Blood-Brain Barrier Transporters: Opportunities for Therapeutic Development in Ischemic Stroke. |
Thomas P Davis, PhD, Patrick T Ronaldson, PhD, FAAPS |
|
2018 |
Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection. |
Patrick T Ronaldson, PhD, FAAPS |
|
2017 |
Blocking CRMP2 SUMOylation reverses neuropathic pain. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2015 |
Blockade of non-opioid excitatory effects of spinal dynorphin A at bradykinin receptors. |
Frank Porreca, PhD, Todd Vanderah, PhD |
|
2016 |
Biphalin: The Foundation of Bivalent Ligands. |
|
|
2023 |
Beta IV spectrin inhibits the metastatic growth of melanoma by suppressing VEGFR2-driven tumor angiogenesis. |
Nam Lee, Ph.D. |
|
2014 |
Behavioral and cellular pharmacology characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan (NAQ) as a mu opioid receptor selective ligand. |
John M. Streicher, PhD |
|
2005 |
Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate AD. |
Jeffrey J. Lochhead, PhD |
|
2005 |
Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results. |
Jeffrey J. Lochhead, PhD |
|
2015 |
Association of endogenous sex hormones with adipokines and ghrelin in postmenopausal women. |
Roberta Diaz Brinton, Ph.D |
|
2022 |
Association Between Specific Type 2 Diabetes Therapies and Risk of Alzheimer's Disease and Related Dementias in Propensity-Score Matched Type 2 Diabetic Patients. |
Roberta Diaz Brinton, Ph.D, Kathleen Rodgers, Ph.D. |
|
2021 |
ApoE4 Impairs Neuron-Astrocyte Coupling of Fatty Acid Metabolism. |
Roberta Diaz Brinton, Ph.D, Fei Yin, Ph.D. |
|
2006 |
AP-2alpha and AP-2gamma are transcriptional targets of p53 in human breast carcinoma cells. |
|
|
2014 |
Antibody-directed coupling of endoglin and MMP-14 is a key mechanism for endoglin shedding and deregulation of TGF-β signaling. |
Nam Lee, Ph.D. |
|
2017 |
Anti-NMDA receptor encephalitis presenting as a primary psychotic disorder. |
Jeffrey J. Lochhead, PhD |
|
2022 |
Antagonism of the mu-delta opioid receptor heterodimer enhances opioid antinociception by activating Src and calcium/calmodulin-dependent protein kinase II signaling. |
John M. Streicher, PhD |
|
2019 |
Animal Models for the Study of Bone-Derived Pain. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2014 |
Animal models for opioid addiction drug discovery. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2016 |
Angiotensin-(1-7)/Mas receptor as an antinociceptive agent in cancer-induced bone pain. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2022 |
Angiotensin-(1-7) improves cognitive function and reduces inflammation in mice following mild traumatic brain injury. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2017 |
Angiostatic actions of capsicodendrin through selective inhibition of VEGFR2-mediated AKT signaling and disregulated autophagy. |
Nam Lee, Ph.D. |
|
2022 |
Androgen-targeting therapeutics mitigate the adverse effect of GnRH agonist on the risk of neurodegenerative disease in men treated for prostate cancer. |
Roberta Diaz Brinton, Ph.D, Kathleen Rodgers, Ph.D. |
|
2017 |
Analgesic Properties of Opioid/NK1 Multitarget Ligands with Distinct in Vitro Profiles in Naive and Chronic Constriction Injury Mice. |
John M. Streicher, PhD |
